{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:11:52Z","timestamp":1753272712327},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0600","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T22:04:24Z","timestamp":1585001064000},"page":"623-629","source":"Crossref","is-referenced-by-count":5,"title":["The risk factors for hepatic steatosis in patients with primary aldosteronism"],"prefix":"10.1507","volume":"67","author":[{"given":"Yui","family":"Shibayama","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"},{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 060-8648 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Radiation Technology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Usubuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Terae","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Sapporo City General Hospital, 060-8604 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 060-8648 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 060-8648 Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66: 607\u2013618.","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Hannemann A, Wallashofski H (2012) Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2014a review of the current literature. Horm Metab Res 44: 157\u2013162.","DOI":"10.1055\/s-0031-1295438"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, et al. (2007) Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25: 177\u2013186.","DOI":"10.1097\/HJH.0b013e3280108e6f"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, et al. (2006) Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91: 454\u2013459.","DOI":"10.1210\/jc.2005-1733"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Luther JM (2014) Effects of aldosterone on insulin sensitivity and secretion. Steroids 91: 54\u201360.","DOI":"10.1016\/j.steroids.2014.08.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Sowers JR, Whaley-Connell A, Epstein M (2009) Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 150: 776\u2013783.","DOI":"10.7326\/0003-4819-150-11-200906020-00005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Targher G, Byrne CD (2013) Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 98: 483\u2013495.","DOI":"10.1210\/jc.2012-3093"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ko YH, Wong TC, Hsu YY, Kuo KL, Yang SH (2017) The correlation between body fat, visceral fat, and nonalcoholic fatty liver disease. Metab Syndr Relat Disord 15: 304\u2013311.","DOI":"10.1089\/met.2017.0001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Srinivasa S, Fitch KV, Quadri N, Maehier P, O\u2019Malley TK, et al. (2018) Significant association of aldosterone and liver fat among HIV-infected individuals with metabolic dysregulation. J Endocr Soc 2: 1147\u20131157.","DOI":"10.1210\/js.2018-00194"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Luo P, Dematteo A, Wang Z, Zhu L, Wang A, et al. (2013) Alosterone deficiency prevents high-fat-feeding-induced hyperglycemia and adipocyte dysfunction in mice. Diabetelogia 56: 901\u2013910.","DOI":"10.1007\/s00125-012-2814-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Fallo F, Dalla Plzza A, Tecchio M, Tona F, Sonino N, et al. (2010) Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. Am J Hypertens 23: 2\u20135.","DOI":"10.1038\/ajh.2009.206"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, et al. (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175: G1\u2013G34.","DOI":"10.1530\/EJE-16-0467"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, et al. (2006) Clinical characteristics of aldosterone producing microadenoma, macroadenoma, and idiopathic hypertaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29: 883\u2013889.","DOI":"10.1291\/hypres.29.883"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, et al. (2004) Role for adrenal venous sampling in primary aldosteromism. Surgery 136: 1227\u20131235.","DOI":"10.1016\/j.surg.2004.06.051"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Monticone S, Viola A, Rossato D, Veglio F, Reincke M, et al. (2015) Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. Lancet Diabetes Endocrinol 3: 296\u2013303.","DOI":"10.1016\/S2213-8587(14)70069-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Webb R, Mathur A, Chang R, Baid S, Niubol N, et al. (2012) What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism. Ann Surg Oncol 19: 1881\u20131886.","DOI":"10.1245\/s10434-011-2121-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Rossi GP, Sacchetto A, Chiesura-corona M, De Toni R, Gallina M, et al. (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnestic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86: 1083\u20131090.","DOI":"10.1210\/jcem.86.3.7287"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Zeb I, Li D, Nasir K, Katz R, Larijani VN, et al. (2012) Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 19: 811\u2013818.","DOI":"10.1016\/j.acra.2012.02.022"},{"key":"19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1148\/radiology.137.3.6934563","volume":"137","author":"J Piekarski","year":"1980","unstructured":"19 Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137: 727\u2013729.","journal-title":"Radiology","ISSN":"http:\/\/id.crossref.org\/issn\/0033-8419","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bydder GM, Chapman RW, Harry D, Bassan L, Sherlock S, et al. (1981) Computed tomography attenuation values in fatty liver. J Comput Tomogr 5: 33\u201335.","DOI":"10.1016\/0149-936X(81)90054-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, et al. (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42: 503\u2013508.","DOI":"10.1016\/j.dld.2009.08.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33.","DOI":"10.1186\/1471-230X-6-33"},{"key":"23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"23 Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846\u2013854.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Stah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, et al. (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7: 1104\u20131112.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Shibayama Y, Wada N, Baba S, Miyano Y, Obara S, et al. (2018) Relationship between visceral fat and plasma aldosterone concentration in patients with primary aldosteronism. J Endocr Soc 2: 1236\u20131245.","DOI":"10.1210\/js.2018-00187"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, et al. (2008) Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48: 449\u2013457.","DOI":"10.1002\/hep.22350"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27 Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, et al. (2004) Beyond insulin resistance in NASH: TNF-alpha or adionectin? Hepatology 40: 46\u201354.","DOI":"10.1002\/hep.20280"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, et al. (2002) Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 36: 403\u2013409.","DOI":"10.1053\/jhep.2002.34738"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29 Musso G, Gambino R, Durazzo M, Biroli G, Carello M, et al. (2005) Adipokines in NASH: postrandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42: 1175\u20131183.","DOI":"10.1002\/hep.20896"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Sun K, Lu J, Jiang Y, Xu M, Xu Y, et al. (2014) Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. Clin Endocrinol (Oxf) 80: 348\u2013355.","DOI":"10.1111\/cen.12168"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Reungjiui S, Hu H, Mu W, Roncal CA, Croker BP, et al. (2007) Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int 72: 1483\u20131492.","DOI":"10.1038\/sj.ki.5002564"},{"key":"32","unstructured":"32 Longo R, Ricci C, Masutti F, Vidimari R, Croce LS, et al. (1993) Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28: 297\u2013302."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/6\/67_EJ19-0600\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:43:44Z","timestamp":1593834224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/6\/67_EJ19-0600\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0600","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}